Caventis Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -1.02%
- Profit Growth -24.49%
- Ebitda 145.08%
- Net Worth 27.69%
- Total Assets -15.02%
About Caventis Pharma
Caventis Pharma Private Limited (CPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 22 August 2012 and has a history of 12 years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kushal Agrawal and Ketan Agrawal serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51909DL2012PTC240513
- Company No.
240513
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Aug 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Caventis Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kushal Agrawal  | Director | 19-Sep-2013 | Current |
| Ketan Agrawal | Director | 22-Oct-2018 | Current |
Financial Performance of Caventis Pharma.
Caventis Pharma Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 1.02% decrease. The company also saw a substantial fall in profitability, with a 24.49% decrease in profit. The company's net worth Soared by an impressive increase of 27.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Caventis Pharma?
In 2020, Caventis Pharma had a promoter holding of 34.00% and a public holding of 66.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rhizoid Healthcare Private LimitedKushal Agrawal and Ketan Agrawal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Caventis Pharma?
Unlock and access historical data on people associated with Caventis Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Caventis Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Caventis Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
